conservative playbook
  • Home
  • Opinions
  • News
  • Videos
  • Contact
  • Home
  • Opinions
  • News
  • Videos
  • Contact
Conservative Playbook
No Result
View All Result
Learn more about RevenueStripe...
Home Opinions
Researcher Speaks Out on Pfizer Covid 'Vaccine' Trial, Calls It a ‘Crazy Mess’

Researcher Speaks Out on Pfizer Covid ‘Vaccine’ Trial, Calls It a ‘Crazy Mess’

On the latest episode of “The Jimmy Dore Show,” comedian and political commentator Jimmy Dore discussed a report by The BMJ on a whistleblower’s revelations about Pfizer’s Phase 3 COVID vaccine trial.

by Jeremy Loffredo
November 13, 2021

Covid variant BA.5 is spreading. It appears milder but much more contagious and evades natural immunity. Best to boost your immune system with new Z-Dtox and Z-Stack nutraceuticals from our dear friend, the late Dr. Vladimir Zelenko.

On the latest episode of “The Jimmy Dore Show,” comedian and political commentator Jimmy Dore discussed the recent bombshell report in The BMJ on Pfizer’s Phase 3 COVID vaccine trial.

The BMJ’s report exposed faked data, blind trial failures, delayed follow-ups on serious adverse reactions and the silencing of researchers who were critical of the trials practices.

A researcher who worked on the trial described the studies to The BMJ as a “crazy mess.”

“Big Pharma are the biggest liars, scammers and criminals in the country — so you know they had to do some shady stuff with the COVID vaccine and sure enough — they did,” said Dore.

Brook Jackson played a central role in the explosive report. Jackson worked as a regional director at Ventavia Research Group, the outside contractor Pfizer hired to conduct the Phase 3 trial.

The BMJ report mentions how in autumn 2020, Pfizer CEO Albert Bourla released an open letter to the billions of people around the world “who were investing their hopes in a safe and effective COVID-19 vaccine to end the pandemic.”

Bourla wrote that the company was “operating at the speed of science.”

“Science says vaccines can’t end the pandemic because they don’t and were never designed to stop transmission,” Dore argued.

We don’t allow Google ads here. We won’t post foot fungus treatments or soft-porn ads like other conservative news outlets. We WILL support MyPillow because they love America. You can support them and me by using promo code “JDR” at checkout.

The BMJ reported:

“ … for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety,” and that “staff who conducted quality control checks were overwhelmed by the volume of problems they were finding.”

Jackson told The BMJ during her two weeks of employment at Ventavia in September 2020, “she repeatedly informed her superiors of poor laboratory management, patient safety concerns  and data integrity issues.”

Documents obtained by The BMJ also showed a Ventavia executive was aware of staff members who were “falsifying data.”

The BMJ reported that on Sept. 25, 2020, Jackson called the U.S. Food and Drug Administration to warn about unsound practices in Pfizer’s clinical trial. She then reported her concerns in an email to the agency.

Later that afternoon Ventavia fired Jackson. According to her separation letter, obtained by The BMJ, the Pfizer subcontractor deemed her “not a good fit.”

Jackson told The BMJ it was the first time she had been fired in her 20-year career in clinical research.

Dore said:

“That’s not how science works. You’re supposed to have people documenting adverse reactions so the vaccines can be made safer. If you want the vaccinated to shut up about their adverse reactions that makes you part of a cover-up.”

According to The BMJ, Jackson listed more than a dozen concerns with the trial, including participants not being monitored by clinical staff after injection, lack of timely follow-up of patients who experienced serious adverse events, protocol deviations not being reported, vaccines not being stored at proper temperatures, mislabelled laboratory specimens and the targeting of Ventavia staff for reporting trial issues.

The BMJ also spoke with two former Ventavia employees who agreed to speak with the medical journal anonymously for “fear of reprisal and loss of job prospects in the tightly knit research community.” Both former Ventavia employees confirmed Jackson’s complaint.

One former employee told the journal she had “worked on over four dozen clinical trials in her career, including many large trials” but had never experienced such a “helter-skelter” environment as with Pfizer’s Phase 3 trial.

The BMJ reported that since Ventavia collaborated with Pfizer for its initial Phase 3 trial, Pfizer hired Ventavia as a research subcontractor on other vaccine clinical trials, including the COVID vaccine for children and young adults, pregnant women and the trials looking at the safety of a booster dose.

“So Pfizer hired them again! Pfizer subcontracts out the risky work so they can have deniability,” Dore said.

John Campbell, Ph.D., discussed The BMJ report in a recent video, asking if the revelations will harm public trust in industry science.

“We should have perfect integrity and transparency all the way through [the scientific process] so the public can completely trust the clinical data … and this doesn’t help with that,” Campbell said.

Learn more about RevenueStripe...

Despite the bombshell revelations, the FDA granted Emergency Use Authorization to the Pfizer COVID vaccine for children ages 5 to11 years old, while the mainstream corporate press gave the BMJ report little to no coverage.

Children’s Health Defense asks those concerned about the FDA’s failure to investigate Jackson’s claims to contact their members of Congress.

Watch the segment here:

© 2021 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

When preparing for societal collapse, don’t forget the water!



Will America-First News Outlets Make it to 2023?

Things are looking grim for conservative and populist news sites.

There’s something happening behind the scenes at several popular conservative news outlets. 2021 was bad, but 2022 is proving to be disastrous for news sites that aren’t “playing ball” with the corporate media narrative. It’s being said that advertisers are cracking down, forcing some of the biggest ad networks like Google and Yahoo to pull their inventory from conservative outlets. This has had two major effects. First, it has cooled most conservative outlets from discussing “taboo” topics like Pandemic Panic Theater, voter fraud, or The Great Reset. Second, it has isolated those ad networks that aren’t playing ball.

Certain topics are anathema for most ad networks. Speaking out against vaccines or vaccine mandates is a certain path to being demonetized. Highlighting voter fraud in the 2020 and future elections is another instant advertising death penalty. Throw in truthful stories about climate change hysteria, Critical Race Theory, and the border crisis and it’s easy to understand how difficult it is for America-First news outlets to spread the facts, share conservative opinions, and still pay the bills.

Without naming names, I have been told of several news outlets who have been forced to either consolidate with larger organizations or who have backed down on covering certain topics out of fear of being “canceled” by the ad networks. I get it. This is a business for many of us and it’s not very profitable. Those of us who do this for a living are often barely squeaking by, so loss of additional revenue can often mean being forced to make cuts. That means not being able to cover the topics properly. Its a Catch-22: Tell the truth and lose the money necessary to keep telling the truth, or avoid the truth and make enough money to survive. Those who have chosen survival simply aren’t able to spread the truth properly.

We will never avoid the truth. The Lord will provide if it is His will. Our job is simply to share the facts, spread the Gospel, and educate as many Americans as possible while exposing the forces of evil.

To those who have the means, we ask that you please donate. We have options available now, but there is no telling when those options will cancel us. We just launched a new GiveSendGo page. We also have our GivingFuel page. There have been many who have been canceled by PayPal, but for now it’s still an option. Your generosity is what keeps these sites running and allows us to get the truth to the masses. We’ve had great success in growing but we know we can do more with your assistance.

Thank you, and God Bless!

JD Rucker



All ORIGINAL content on this site is © 2021 NOQ Report. All REPUBLISHED content has received direct or implied permission for reproduction.

With that said, our content may be reproduced and distributed as long as it has a link to the original source and the author is credited prominently. We don’t mind you using our content as long as you help out by giving us credit with a prominent link. If you feel like giving us a tip for the content, we will not object!

JD Rucker – EIC
@jdrucker


 

Tags: Children's Health DefenseCoronavirusCOVID-19LedeTop StoryVaccines

Bypass Big Tech Censors



My Shows

The JD Rucker Show (Rumble)
The JD Rucker Podcast (Apple)
Red State Talk Radio (M-F 2pm ET)
America Out Loud (M-F 7pm ET)
America First Report (Substack)
The Late Prepper (Substack)
End Medical Tyranny (Substack)

Our Sponsors

 
MyPillow Promo Code NOQ

MyPatriotSupply

Z-Stack Life

Our Gold Guy
 
Valley Food
 

Shows

Biden-Harris Regime "Failures"

Council for Inclusive Capitalism

Fighting Inflation

Arrest the Teachers

Controlled Demolition of Biden

Are We Under Attack

Bypass Big Tech Censors

Copyright © 2021 NOQ Report.

No Result
View All Result
  • Home
  • Opinions
  • News
  • Videos
  • Contact

© 2020 NOQ Report

Session expired

Please log in again. The login page will open in a new tab. After logging in you can close it and return to this page.

>